Eisenmenger Syndrome: A Revisit of a Hidden but Catastrophic Disease

J. M. Chinawa, I. Arodiwe, J. T. Onyia, A. T. Chinawa
University of Nigeria/University of Nigeria Teaching Hospital. Enugu State University College of Medicine.
Nigeria

West African Journal of Medicine
West Afr J Med 2023; 40: 973-981
DOI Not Available

Abstract
Background: Eisenmenger syndrome (ES) is a rare condition seen in children with congenital heart disease (CHD). It is characterized by raised pulmonary vascular resistance (PVR) arising from a shunt reversal with the presence of desaturated blood in the systemic circulation. Proper timing and early intervention in children with congenital heart disease have made the syndrome a rare occurrence. However, this cannot be said in developing countries where facilities for the diagnosis and management of children with congenital heart disease are not optimal.
Objectives: The aim of this narrative review is to highlight the importance of early diagnosis and to review the new techniques in the evaluation of children with ES. It also highlights in a snapshot the state of management of ES in a developing country.
Methods: A search for published data on ES was done through several search engines such as Pubmed, google scholar citation, systematic reviews, and meta-analysis. This involves research done over the past 30 years. Keywords such as Eisenmenger’syndrome, ‘congenital heart defect’, ‘Pulmonary hypertension’, ‘catherterization’, ‘echocardiography’, and children’ were used.
Results: This review shows the new technique in the diagnosis, aetio-pathogenesis, management and treatment of children with ES in-depth descriptive analysis and new advances in the management of children with ES.
Conclusion: Eisenmenger syndrome is a preventable disease that can be curbed by early diagnosis and treatment of children with congenital heart disease, especially in the developing world.

Category
Class I. Pulmonary Hypertension Associated with Congenital Cardiovascular Disease
Review Articles Concerning Pulmonary Vascular Disease

Age Focus: Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication

Article Access
Free PDF File or Full Text Article Available Through PubMed or DOI: No

Scroll to Top